Emmy Manders1, Harm-Jan Bogaard2, M Louis Handoko3, Marielle C van de Veerdonk2, Anne Keogh4, Nico Westerhof1, Ger J M Stienen5, Cristobal G Dos Remedios6, Marc Humbert7, Peter Dorfmüller8, Elie Fadel9, Christophe Guignabert10, Jolanda van der Velden11, Anton Vonk-Noordegraaf2, Frances S de Man12, Coen A C Ottenheijm13. 1. Department of Pulmonology, Vrije Universiteit (VU) University Medical Center, Amsterdam, the Netherlands; Department of Physiology, VU University Medical Center, Amsterdam, the Netherlands. 2. Department of Pulmonology, Vrije Universiteit (VU) University Medical Center, Amsterdam, the Netherlands. 3. Department of Physiology, VU University Medical Center, Amsterdam, the Netherlands; Cardiology Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, the Netherlands. 4. Heart Transplant Unit, St. Vincent's Hospital, Sydney, Australia. 5. Department of Physiology, VU University Medical Center, Amsterdam, the Netherlands; Department of Physics and Astronomy, VU University, Amsterdam, the Netherlands. 6. Muscle Research Unit, Bosch Institute, The University of Sydney, Sydney, Australia. 7. University of Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France; Assistance Publique-Hôpitaux de Paris, Service de Pneumologie, Département Hospitalo-Universitaire, Thorax Innovation (DHU TORINO), Hôpital Bicêtre, Le Kremlin-Bicêtre, France; Inserm U999, Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique (LabEx LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France. 8. University of Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France; Inserm U999, Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique (LabEx LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France; Service d'Anatomie Pathologique, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France. 9. University of Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France; Inserm U999, Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique (LabEx LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France; Service de Chirurgie Thoracique, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France. 10. University of Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France; Inserm U999, Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique (LabEx LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France. 11. Department of Physiology, VU University Medical Center, Amsterdam, the Netherlands; ICIN Netherlands Heart Institute, Utrecht, the Netherlands. 12. Department of Pulmonology, Vrije Universiteit (VU) University Medical Center, Amsterdam, the Netherlands. Electronic address: fs.deman@vumc.nl. 13. Department of Physiology, VU University Medical Center, Amsterdam, the Netherlands. Electronic address: c.ottenheijm@vumc.nl.
Abstract
BACKGROUND: After lung transplantation, increased left ventricular (LV) filling can lead to LV failure, increasing the risk of post-operative complications and mortality. LV dysfunction in pulmonary arterial hypertension (PAH) is characterized by a reduced LV ejection fraction and impaired diastolic function. OBJECTIVES: The pathophysiology of LV dysfunction in PAH is incompletely understood. This study sought to assess the contribution of atrophy and contractility of cardiomyocytes to LV dysfunction in PAH patients. METHODS: LV function was assessed by cardiac magnetic resonance imaging. In addition, LV biopsies were obtained in 9 PAH patients and 10 donors. The cross-sectional area (CSA) and force-generating capacity of isolated single cardiomyocytes was investigated. RESULTS: Magnetic resonance imaging analysis revealed a significant reduction in LV ejection fraction in PAH patients, indicating a reduction in LV contractility. The CSA of LV cardiomyocytes of PAH patients was significantly reduced (~30%), indicating LV cardiomyocyte atrophy. The maximal force-generating capacity, normalized to cardiomyocyte CSA, was significantly reduced (~25%). Also, a reduction in the number of available myosin-based cross-bridges was found to cause the contractile weakness of cardiomyocytes. This finding was supported by protein analyses, which showed an ~30% reduction in the myosin/actin ratio in cardiomyocytes from PAH patients. Finally, the phosphorylation level of sarcomeric proteins was reduced in PAH patients, which was accompanied by increased calcium sensitivity of force generation. CONCLUSIONS: The contractile function and the CSA of LV cardiomyocytes is substantially reduced in PAH patients. We propose that these changes contribute to the reduced in vivo contractility of the LV in PAH patients.
BACKGROUND: After lung transplantation, increased left ventricular (LV) filling can lead to LV failure, increasing the risk of post-operative complications and mortality. LV dysfunction in pulmonary arterial hypertension (PAH) is characterized by a reduced LV ejection fraction and impaired diastolic function. OBJECTIVES: The pathophysiology of LV dysfunction in PAH is incompletely understood. This study sought to assess the contribution of atrophy and contractility of cardiomyocytes to LV dysfunction in PAH patients. METHODS: LV function was assessed by cardiac magnetic resonance imaging. In addition, LV biopsies were obtained in 9 PAH patients and 10 donors. The cross-sectional area (CSA) and force-generating capacity of isolated single cardiomyocytes was investigated. RESULTS: Magnetic resonance imaging analysis revealed a significant reduction in LV ejection fraction in PAH patients, indicating a reduction in LV contractility. The CSA of LV cardiomyocytes of PAH patients was significantly reduced (~30%), indicating LV cardiomyocyte atrophy. The maximal force-generating capacity, normalized to cardiomyocyte CSA, was significantly reduced (~25%). Also, a reduction in the number of available myosin-based cross-bridges was found to cause the contractile weakness of cardiomyocytes. This finding was supported by protein analyses, which showed an ~30% reduction in the myosin/actin ratio in cardiomyocytes from PAH patients. Finally, the phosphorylation level of sarcomeric proteins was reduced in PAH patients, which was accompanied by increased calcium sensitivity of force generation. CONCLUSIONS: The contractile function and the CSA of LV cardiomyocytes is substantially reduced in PAH patients. We propose that these changes contribute to the reduced in vivo contractility of the LV in PAH patients.
Authors: Reza Avazmohammadi; Emilio A Mendiola; João S Soares; David S Li; Zhiqiang Chen; Samer Merchant; Edward W Hsu; Peter Vanderslice; Richard A F Dixon; Michael S Sacks Journal: Ann Biomed Eng Date: 2018-09-27 Impact factor: 3.934
Authors: Dale A Burkett; Cameron Slorach; Sonali S Patel; Andrew N Redington; D Dunbar Ivy; Luc Mertens; Adel K Younoszai; Mark K Friedberg Journal: Circ Cardiovasc Imaging Date: 2016-09 Impact factor: 7.792
Authors: Dale A Burkett; Cameron Slorach; Sonali S Patel; Andrew N Redington; D Dunbar Ivy; Luc Mertens; Adel K Younoszai; Mark K Friedberg Journal: Circ Cardiovasc Imaging Date: 2015-08 Impact factor: 7.792
Authors: Mary K Porteous; Bonnie Ky; James N Kirkpatrick; Russell Shinohara; Joshua M Diamond; Rupal J Shah; James C Lee; Jason D Christie; Steven M Kawut Journal: Am J Respir Crit Care Med Date: 2016-06-15 Impact factor: 21.405
Authors: E Ostenfeld; S S Stephensen; K Steding-Ehrenborg; E Heiberg; H Arheden; G Rådegran; J Holm; M Carlsson Journal: Int J Cardiovasc Imaging Date: 2016-05-03 Impact factor: 2.357
Authors: W Linke; C G Dos Remedios; S P Lal; A Li; J McNamara; A Keogh; P S Macdonald; R Cooke; E Ehler; R Knöll; S B Marston; J Stelzer; H Granzier; C Bezzina; S van Dijk; F De Man; G J M Stienen; J Odeberg; F Pontén; J van der Velden Journal: Biophys Rev Date: 2017-08-14
Authors: Michaela Yuen; Sandra T Cooper; Steve B Marston; Kristen J Nowak; Elyshia McNamara; Nancy Mokbel; Biljana Ilkovski; Gianina Ravenscroft; John Rendu; Josine M de Winter; Lars Klinge; Alan H Beggs; Kathryn N North; Coen A C Ottenheijm; Nigel F Clarke Journal: Hum Mol Genet Date: 2015-08-24 Impact factor: 6.150
Authors: Henrik Finsberg; Ce Xi; Xiaodan Zhao; Ju Le Tan; Martin Genet; Joakim Sundnes; Lik Chuan Lee; Liang Zhong; Samuel T Wall Journal: Am J Physiol Heart Circ Physiol Date: 2019-11-01 Impact factor: 4.733